Interleukin 10

Whitney W. Stevens; Larry Borish; John W. Steinke

doi:10.1002/9781444346688.ch17

Interleukin 10

Whitney W. Stevens^*, Larry Borish, John W. Steinke

^*Corresponding author for this work

Medicine, Allergy Division

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Scopus citations

Original language	English (US)
Title of host publication	Inflammation and Allergy Drug Design
Publisher	Wiley-Blackwell
Pages	215-224
Number of pages	10
ISBN (Print)	9781444330144
DOIs	https://doi.org/10.1002/9781444346688.ch17
State	Published - Jul 27 2011

Keywords

Dendritic cells/M2 macrophages - IL-10, by innate immune cells, as macrophage
Expression of IL-10, central to maintenance - of immune nonresponsiveness to allergens
IL-10, identified - as a Th2 lymphocyte product
IL-10, inhibiting major histocompatibility complex (MHC) class II expression - on APCs and dendritic cells (DCs)
Immunotherapy mechanisms, and interleukin 10 - immune deviation from Th2, toward a Th1-like response
Interleukin 10 (IL-10), immunoregulatory cytokine - with multiple biologic effects on cell types
Interleukin 10 signaling - binding to heterodimer receptor complex, IL-10 receptor 1 and IL-10R2 chains
Interleukin 10, and CD4+ lymphocytes - regulatory T lymphocyte families, nTreg, iTreg and Th3 cells
Potential utility of direct IL-10 administration - as asthma therapeutic
Sources of interleukin 10 - immature DCs and B cells, major sources of IL-10 in humans

ASJC Scopus subject areas

General Pharmacology, Toxicology and Pharmaceutics
General Medicine

Access to Document

10.1002/9781444346688.ch17

Cite this

@inbook{c66e1bba09de4fd5ae41fd3419973896,

title = "Interleukin 10",

keywords = "Dendritic cells/M2 macrophages - IL-10, by innate immune cells, as macrophage, Expression of IL-10, central to maintenance - of immune nonresponsiveness to allergens, IL-10, identified - as a Th2 lymphocyte product, IL-10, inhibiting major histocompatibility complex (MHC) class II expression - on APCs and dendritic cells (DCs), Immunotherapy mechanisms, and interleukin 10 - immune deviation from Th2, toward a Th1-like response, Interleukin 10 (IL-10), immunoregulatory cytokine - with multiple biologic effects on cell types, Interleukin 10 signaling - binding to heterodimer receptor complex, IL-10 receptor 1 and IL-10R2 chains, Interleukin 10, and CD4+ lymphocytes - regulatory T lymphocyte families, nTreg, iTreg and Th3 cells, Potential utility of direct IL-10 administration - as asthma therapeutic, Sources of interleukin 10 - immature DCs and B cells, major sources of IL-10 in humans",

author = "Stevens, {Whitney W.} and Larry Borish and Steinke, {John W.}",

year = "2011",

month = jul,

day = "27",

doi = "10.1002/9781444346688.ch17",

language = "English (US)",

isbn = "9781444330144",

pages = "215--224",

booktitle = "Inflammation and Allergy Drug Design",

publisher = "Wiley-Blackwell",

}

TY - CHAP

T1 - Interleukin 10

AU - Stevens, Whitney W.

AU - Borish, Larry

AU - Steinke, John W.

PY - 2011/7/27

Y1 - 2011/7/27

KW - Dendritic cells/M2 macrophages - IL-10, by innate immune cells, as macrophage

KW - Expression of IL-10, central to maintenance - of immune nonresponsiveness to allergens

KW - IL-10, identified - as a Th2 lymphocyte product

KW - IL-10, inhibiting major histocompatibility complex (MHC) class II expression - on APCs and dendritic cells (DCs)

KW - Immunotherapy mechanisms, and interleukin 10 - immune deviation from Th2, toward a Th1-like response

KW - Interleukin 10 (IL-10), immunoregulatory cytokine - with multiple biologic effects on cell types

KW - Interleukin 10 signaling - binding to heterodimer receptor complex, IL-10 receptor 1 and IL-10R2 chains

KW - Interleukin 10, and CD4+ lymphocytes - regulatory T lymphocyte families, nTreg, iTreg and Th3 cells

KW - Potential utility of direct IL-10 administration - as asthma therapeutic

KW - Sources of interleukin 10 - immature DCs and B cells, major sources of IL-10 in humans

UR - http://www.scopus.com/inward/record.url?scp=84885550497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885550497&partnerID=8YFLogxK

U2 - 10.1002/9781444346688.ch17

DO - 10.1002/9781444346688.ch17

M3 - Chapter

AN - SCOPUS:84885550497

SN - 9781444330144

SP - 215

EP - 224

BT - Inflammation and Allergy Drug Design

PB - Wiley-Blackwell

ER -

Interleukin 10

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this